FDA Approved: BILPREVDA — Original Application (Organon LLC)

View source ↗

Summary

The FDA approved Bilprevda (denosumab) from Organon LLC under an Original Biologics License Application. The product is approved for postmenopausal osteoporosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Postmenopausal Osteoporosis

Drugs mentioned

• BILPREVDA (DENOSUMAB)

Snippet

ORIG AP for BILPREVDA (DENOSUMAB)